Herbert Smith Freehills Kramer LLP

The patent group at Herbert Smith Freehills Kramer LLP counsels clients in relation to a range of IP-heavy transactions and R&D deals, coordinates cross-border litigation involving the UPC, and is particularly experienced in litigating disputes for innovators in the pharmaceutical sector. The team, which works under the leadership of life sciences specialist Sebastian Moore, is also equipped to advise a range of clients on SPCs, hi-tech patent litigation, and more. Andrew Moir is a key contact for digital and tech patent matters, including SEP and FRAND litigation, and Andrew Wells is a highly experienced litigator across various innovation-intensive industries. Emily Bottle, who pivots between the firm’s London and Milan offices, handles life sciences disputes, and Jonathan Turnbull specialises in disputes stemming from R&D agreements. Emma Sherratt‘s remit includes patent validity and freedom-to-operate work in the pharma and life sciences sectors, and George McCubbin is involved in non-contentious and contentious pharma matters. Monika Klajn and Priyanka Madan are further names to note.